Candesartan Cilexetil, a Novel Angiotensin II Antagonist, Provides Dose-dependent Antihypertensive Effect with Maintained Tolerability

By ELMFELDT D.   GEORGE M.   HÜBNER R.   OLOFSSON B.  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 54-54

Informa Healthcare

Access to resources Recommend Favorite

Antihypertensive Effects and Tolerability of Candesartan Cilexetil in an Elderly Population

By MCINNES G. T.   JONKER J.  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 58-58

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Tolerability of a Combination Tablet of Candesartan Cilexetil and Hydrochlorothiazide in Insufficiently Controlled Primary Hypertension - Comparison with a Combination of Losartan and Hydrochlorothiazide

By ÖHMAN K. PETER   MILON HUGUES   VALNES KOLBJØRN  

Blood Pressure, Vol. 9, Iss. 4, 2000-09 ,pp. : 214-220

Informa Healthcare

Access to resources Recommend Favorite

Candesartan Cilexetil, 16 mg, Provides a Greater Antihypertensive Effect than Losartan, 50 mg, in Patients with Mild to Moderate Hypertension

By ANDERSSON O. K.   NELDAM S.  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 55-55

Informa Healthcare

Access to resources Recommend Favorite

Candesartan, an Insurmountable Antagonist of Angiotensin II-mediated Contractile Effects in Isolated Vascular Preparations: Comparison with Irbesartan, Losartan and its Active Metabolite (EXP-3174)

By MORSING P.   BRANDT-ELIASSON U.   RENBERG L.   ABRAHAMSSON T.  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 50-51

Informa Healthcare

Access to resources Recommend Favorite